Article info
PDFTherapeutic Intervention
Intravenous Immunoglobulin – How to use it
Citation
Intravenous Immunoglobulin – How to use it
Publication history
- First published December 1, 2001.
Online issue publication
December 01, 2001
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2001 BMJ
Other content recommended for you
- Intravenous immunoglobulin in neurological disease: a specialist review
- Original research: Second IVIg course in Guillain - Barré syndrome with poor prognosis: the non-randomised ISID study
- Sialylated IgG - Fc: a novel biomarker of chronic inflammatory demyelinating polyneuropathy
- Small volume plasma exchange for Guillain - Barré syndrome in resource - limited settings: a phase II safety and feasibility study
- What ’s new in Guillain - Barré syndrome
- Guillain Barré syndrome precipitated by the use of antilymphocyte globulin in the treatment of severe aplastic anaemia
- Treatment dilemmas in Guillain - Barré syndrome
- Outcome and its predictors in Guillain – Barré syndrome
- Southern Regional Meeting Abstracts
- Immune responses to myelin proteins in Guillain – Barré syndrome